Index -
P/E -
EPS (ttm) -1.01
Insider Own 0.40%
Shs Outstand 193.80M
Perf Week -3.97%
Market Cap 13.97B
Forward P/E 15.76
EPS next Y 4.56
Insider Trans -2.15%
Shs Float 193.42M
Perf Month -3.61%
Income -193.80M
PEG -
EPS next Q 0.97
Inst Own 102.69%
Short Float 2.65%
Perf Quarter -8.63%
Sales 3.91B
P/S 3.57
EPS this Y 14.39%
Inst Trans -10.08%
Short Ratio 3.17
Perf Half Y 22.33%
Book/sh 20.99
P/B 3.43
EPS next Y 18.35%
ROA -1.71%
Short Interest 5.12M
Perf Year -0.08%
Cash/sh 2.25
P/C 32.02
EPS next 5Y 15.14%
ROE -4.65%
52W Range 42.09 - 82.75
Perf YTD 4.67%
Dividend Est. 0.44 (0.61%)
P/FCF 45.44
EPS past 5Y -
ROI -2.06%
52W High -13.09%
Beta 1.62
Dividend TTM 0.42 (0.58%)
Quick Ratio 1.65
Sales past 5Y 11.09%
Gross Margin 48.22%
52W Low 70.87%
ATR (14) 2.14
Dividend Ex-Date May 16, 2024
Current Ratio 1.65
EPS Y/Y TTM -172.70%
Oper. Margin 18.13%
RSI (14) 38.62
Volatility 2.40% 2.40%
Employees 13200
Debt/Eq 1.34
Sales Y/Y TTM 4.92%
Profit Margin -4.95%
Recom 1.53
Target Price 89.65
Option/Short Yes / Yes
LT Debt/Eq 1.31
EPS Q/Q 22.85%
Payout -
Rel Volume 1.21
Prev Close 72.30
Sales Surprise 4.42%
EPS Surprise 13.38%
Sales Q/Q 8.60%
Earnings Apr 25 BMO
Avg Volume 1.61M
Price 71.92
SMA20 -6.72%
SMA50 -5.23%
SMA200 1.91%
Trades
Volume 1,956,596
Change -0.53%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-01-24 Upgrade
BofA Securities
Underperform → Neutral
$65 → $90
Dec-19-23 Initiated
Oppenheimer
Outperform
$81
Oct-25-23 Downgrade
Evercore ISI
Outperform → In-line
Oct-25-23 Downgrade
BofA Securities
Buy → Underperform
$95 → $44
Apr-26-23 Upgrade
Needham
Hold → Buy
$84
Mar-01-23 Upgrade
Exane BNP Paribas
Neutral → Outperform
$80
Feb-01-23 Upgrade
BofA Securities
Neutral → Buy
$72 → $91
Jan-13-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$70 → $88
Jan-06-23 Initiated
Exane BNP Paribas
Neutral
$64.50
Jan-04-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$80 → $78
Dec-02-22 Downgrade
Barclays
Overweight → Equal Weight
Oct-19-22 Resumed
Jefferies
Buy
$109 → $70
Jul-27-22 Downgrade
BofA Securities
Buy → Neutral
$119 → $86
Jul-13-22 Initiated
Wells Fargo
Equal Weight
$88
Mar-30-22 Initiated
Deutsche Bank
Buy
$124
Mar-18-22 Downgrade
Goldman
Buy → Neutral
$125 → $109
Mar-11-22 Resumed
BofA Securities
Buy
$119
Feb-23-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$102
Jan-27-22 Downgrade
Truist
Buy → Hold
$105
Jan-20-22 Resumed
Barclays
Overweight
$125
Show Previous Ratings
May-30-24 11:45AM
May-29-24 09:50AM
May-28-24 06:00AM
May-23-24 08:00AM
May-22-24 09:00AM
06:50AM
Loading…
06:50AM
May-21-24 08:02AM
08:00AM
May-16-24 08:05AM
08:00AM
May-14-24 11:00AM
08:00AM
May-13-24 09:50AM
May-08-24 08:00AM
06:00AM
06:50PM
Loading…
May-07-24 06:50PM
05:30AM
(The Wall Street Journal)
May-06-24 03:43PM
(Investor's Business Daily)
May-04-24 09:21AM
02:30AM
May-03-24 06:50AM
May-01-24 08:00AM
Apr-30-24 01:15PM
12:10PM
08:00AM
06:00AM
Apr-27-24 01:02AM
Apr-26-24 02:03AM
(Thomson Reuters StreetEvents)
Apr-25-24 04:51PM
(Morningstar Research) +8.17%
12:33PM
(Associated Press Finance)
10:55AM
Loading…
10:55AM
09:57AM
09:30AM
07:34AM
07:30AM
06:27AM
(Associated Press Finance)
06:19AM
Apr-22-24 09:16AM
Apr-19-24 11:56AM
Apr-18-24 10:01AM
08:00AM
Apr-17-24 09:00AM
Apr-11-24 06:30AM
Apr-05-24 12:44PM
Apr-04-24 08:00AM
Apr-03-24 01:31AM
Apr-02-24 09:36AM
08:00AM
Mar-26-24 06:50AM
Mar-25-24 04:21PM
01:37PM
Mar-21-24 08:00AM
05:33AM
Mar-20-24 02:23PM
Mar-18-24 07:01PM
Mar-17-24 08:30AM
(The Wall Street Journal)
Mar-14-24 03:49PM
11:30AM
Mar-13-24 08:00AM
Mar-08-24 01:04PM
Mar-07-24 06:50AM
Mar-06-24 11:28PM
08:00AM
Mar-05-24 10:42AM
Mar-01-24 12:07AM
Feb-29-24 11:39AM
Feb-28-24 08:00AM
Feb-27-24 08:00AM
Feb-22-24 08:00AM
06:50AM
Feb-21-24 06:00AM
Feb-20-24 07:32AM
Feb-14-24 08:53AM
02:35AM
(Thomson Reuters StreetEvents)
Feb-13-24 05:01PM
09:30AM
07:35AM
06:34AM
06:32AM
(Associated Press Finance)
06:21AM
Feb-08-24 01:35PM
09:15AM
08:00AM
Feb-06-24 10:00AM
Feb-04-24 07:00PM
Feb-01-24 08:00AM
05:45AM
Jan-31-24 08:01AM
07:59AM
Jan-30-24 08:00AM
Jan-25-24 08:00AM
07:45AM
Jan-23-24 12:11PM
Jan-19-24 09:29AM
Jan-17-24 08:00AM
Jan-16-24 06:50AM
Jan-10-24 04:53PM
08:00AM
Jan-09-24 06:00AM
Jan-04-24 02:08PM
TransUnion engages in the provision of information and risk management solutions. It also provides consumer reports, risk scores, analytical services, and decision-making capabilities to businesses. It operates through the following segments: U.S. Markets, International, Consumer Interactive, and Corporate. The U.S. Markets segment provides consumer reports, risk scores, analytical services, and decision-making capabilities to businesses. The International segment provides credit reports, analytics and decision-making services and other value-added risk management services. The Consumer Interactive segment offers solutions that help consumers manage their personal finances and take precautions against identity theft. The Corporate segment provides support services to each segment, holds investments, and conducts enterprise functions. The company was founded on February 15, 2012, and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CHAOUKI STEVEN M President, US Markets May 01 '24 Sale 73.15 1,776 129,914 73,323 May 03 04:18 PM CHAOUKI STEVEN M President, US Markets & CI Apr 01 '24 Sale 81.30 1,775 144,308 75,099 Apr 02 06:44 PM MAULDIN RICHARD DANE EVP - Operations Mar 14 '24 Sale 78.10 1,500 117,150 22,033 Mar 18 04:59 PM Martin Timothy J EVP - Global Solutions Mar 05 '24 Sale 78.59 12,000 943,080 54,522 Mar 06 06:18 PM MONAHAN THOMAS L Director Nov 17 '23 Buy 57.46 1,800 103,421 19,071 Nov 20 04:43 PM Zukauckas Linda Director Oct 30 '23 Buy 43.62 2,350 102,507 7,781 Oct 31 04:58 PM CHAOUKI STEVEN M President, US Markets & CI Oct 02 '23 Sale 71.43 1,276 91,145 56,860 Oct 03 04:45 PM CHAOUKI STEVEN M President, US Markets & CI Sep 01 '23 Sale 82.06 1,277 104,791 58,136 Sep 05 04:53 PM Williams Jennifer A. SVP, Chief Accounting Officer Aug 28 '23 Sale 79.36 236 18,729 2,425 Aug 29 04:57 PM CHAOUKI STEVEN M President, US Markets & CI Aug 22 '23 Sale 77.03 949 73,101 60,472 Aug 23 04:45 PM MAULDIN RICHARD DANE EVP - Operations Aug 08 '23 Sale 77.02 2,000 154,040 21,181 Aug 10 05:10 PM CHAOUKI STEVEN M President, US Markets & CI Jul 24 '23 Sale 80.31 951 76,375 61,421 Jul 26 05:22 PM Dhar Abhi Former EVP, Chief Info & Tech Jun 29 '23 Sale 80.00 3,500 280,000 69,702 Jul 03 04:35 PM CHAOUKI STEVEN M President, US Markets & CI Jun 22 '23 Sale 73.66 951 70,051 62,372 Jun 23 04:49 PM Skinner Todd C. President, International Jun 06 '23 Sale 74.49 18,470 1,375,830 18,561 Jun 07 04:46 PM
Index -
P/E -
EPS (ttm) -1.53
Insider Own 21.50%
Shs Outstand 21.84M
Perf Week 24.67%
Market Cap 103.74M
Forward P/E -
EPS next Y -
Insider Trans 15.21%
Shs Float 17.14M
Perf Month 62.67%
Income -23.72M
PEG -
EPS next Q -0.41
Inst Own 3.03%
Short Float 7.15%
Perf Quarter 240.50%
Sales 0.00M
P/S -
EPS this Y -6.02%
Inst Trans 101.50%
Short Ratio 3.01
Perf Half Y 395.51%
Book/sh -0.28
P/B -
EPS next Y -
ROA -266.70%
Short Interest 1.22M
Perf Year 90.00%
Cash/sh 0.38
P/C 12.54
EPS next 5Y -
ROE -440.12%
52W Range 0.82 - 4.59
Perf YTD 305.98%
Dividend Est. -
P/FCF -
EPS past 5Y -25.01%
ROI -
52W High 3.41%
Beta 0.33
Dividend TTM -
Quick Ratio 1.77
Sales past 5Y 0.00%
Gross Margin -
52W Low 479.27%
ATR (14) 0.36
Dividend Ex-Date -
Current Ratio 1.77
EPS Y/Y TTM 6.40%
Oper. Margin 0.00%
RSI (14) 80.11
Volatility 12.57% 9.82%
Employees 13
Debt/Eq -
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 14.00
Option/Short No / Yes
LT Debt/Eq -
EPS Q/Q -22.21%
Payout -
Rel Volume 1.02
Prev Close 4.39
Sales Surprise -
EPS Surprise 0.00%
Sales Q/Q -
Earnings Nov 07 BMO
Avg Volume 407.36K
Price 4.75
SMA20 38.50%
SMA50 69.53%
SMA200 152.42%
Trades
Volume 414,671
Change 8.20%
May-17-24 08:37AM
May-16-24 08:37AM
Apr-30-24 08:08AM
Apr-29-24 08:08AM
Apr-23-24 08:51AM
08:01AM
Loading…
Apr-05-24 08:01AM
Mar-28-24 03:00PM
Mar-26-24 03:00PM
08:01AM
Mar-22-24 03:00PM
Mar-21-24 03:00PM
Mar-16-24 01:49AM
Mar-07-24 09:45AM
Mar-06-24 11:04AM
08:48AM
08:45AM
Loading…
Mar-05-24 08:45AM
Feb-27-24 10:30AM
Feb-22-24 10:30AM
Feb-07-24 08:01AM
Jan-24-24 07:15AM
Jan-17-24 09:00AM
Jan-05-24 08:00AM
Dec-19-23 07:00AM
Dec-01-23 09:55AM
Nov-17-23 03:52PM
09:00AM
Nov-15-23 09:35AM
Nov-10-23 07:01AM
Nov-07-23 09:01AM
08:15AM
09:00AM
Loading…
Oct-31-23 09:00AM
Oct-30-23 08:41AM
Oct-24-23 08:00AM
Oct-19-23 08:35AM
Oct-17-23 09:00AM
08:01AM
Oct-12-23 09:20AM
Oct-10-23 11:15AM
08:01AM
Oct-03-23 08:01AM
Sep-28-23 08:01AM
Aug-21-23 09:55AM
Aug-15-23 10:20AM
Aug-08-23 08:00AM
Jul-11-23 08:00AM
Jul-10-23 08:00AM
Jun-20-23 08:00AM
Jun-07-23 08:00AM
May-08-23 08:00AM
May-01-23 06:45AM
Apr-27-23 04:10PM
Apr-24-23 09:06PM
09:00AM
Apr-20-23 08:00AM
Apr-18-23 08:52AM
Apr-12-23 02:17PM
08:00AM
Apr-11-23 02:43PM
08:00AM
Mar-24-23 04:30PM
Mar-13-23 10:04AM
Mar-07-23 08:00AM
Feb-13-23 12:07PM
Jan-17-23 10:00AM
08:00AM
Jan-05-23 08:00AM
Dec-20-22 08:00AM
Dec-13-22 08:00AM
Dec-12-22 08:00AM
Nov-22-22 08:00AM
Nov-15-22 08:00AM
Nov-09-22 04:15PM
Nov-08-22 03:40PM
Oct-12-22 07:30AM
Oct-06-22 08:00AM
Oct-04-22 07:30AM
Sep-30-22 09:00AM
Sep-29-22 09:01AM
Sep-08-22 08:00AM
Sep-06-22 08:00AM
Aug-30-22 11:07AM
Aug-22-22 08:00AM
Aug-02-22 08:00AM
Aug-01-22 03:30PM
Jul-27-22 07:52PM
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Smith Stan Director Apr 25 '24 Buy 2.03 147,492 299,409 1,005,060 Apr 26 05:30 PM Louie Ngar Yee Director Apr 25 '24 Buy 2.03 19,665 39,920 1,167,189 Apr 26 05:33 PM Smith Stan Director Mar 14 '24 Buy 1.17 170,940 200,000 857,568 Mar 15 07:11 PM Louie Ngar Yee Director Mar 14 '24 Buy 1.17 170,940 200,000 1,147,524 Mar 15 07:09 PM Luput Cristian Director Mar 14 '24 Buy 1.17 69,282 81,060 367,350 Mar 15 07:08 PM CHAOUKI STEVEN M Director Mar 14 '24 Buy 1.17 34,641 40,530 88,891 Mar 18 05:34 PM Guerrero Ramiro Director Mar 14 '24 Buy 1.17 6,928 8,106 319,600 Mar 15 07:04 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite